Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Mediar Therapeutics, Inc. See All Filings	D	2025-12-23 09:59:09 UTC
Amount To Be Raised $75,699,630 Associated Brokers / Dealers N/A CIK Number 0001766784 Filed Document 0001766784-25-000002 Exclusions or Exemptions 506b Accepted Date 2025-12-23 09:59:09 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Mediar Therapeutics, Inc. See All Filings	D/A	2024-10-22 14:32:29 UTC
Amount To Be Raised $85,034,866 Associated Brokers / Dealers N/A CIK Number 0001766784 Filed Document 0001766784-24-000002 Exclusions or Exemptions 506b Accepted Date 2024-10-22 14:32:29 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Mediar Therapeutics, Inc. See All Filings	D/A	2023-11-09 13:40:35 UTC
Amount To Be Raised $85,034,867 Associated Brokers / Dealers N/A CIK Number 0001766784 Filed Document 0001766784-23-000002 Exclusions or Exemptions 506b Accepted Date 2023-11-09 13:40:35 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Mediar Therapeutics, Inc. See All Filings	D	2022-12-02 16:59:34 UTC
Amount To Be Raised $31,761,186 Associated Brokers / Dealers N/A CIK Number 0001766784 Filed Document 0001766784-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-12-02 16:59:34 UTC Type of Offering D Industry Other Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Mediar Therapeutics, Inc. See All Filings	D	2019-02-06 16:06:52 UTC
Amount To Be Raised $10,000,000 Associated Brokers / Dealers N/A CIK Number 0001766784 Filed Document 0001766784-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-02-06 16:06:52 UTC Type of Offering D Industry Other Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity